Enliven Therapeutics Inc
(ELVN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1996 | 12-1995 | 09-1995 | 06-1995 | 03-1995 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 0 | 1,240 | 1,270 | 1,530 | 1,400 |
| TOTAL | $N/A | $1,240 | $1,270 | $1,530 | $1,400 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 5,930 | 6,910 | 3,940 | 4,910 |
| Other Non-Current Assets | 0 | 13,000 | 13,770 | 14,180 | 14,350 |
| TOTAL | $N/A | $18,930 | $20,680 | $18,120 | $19,260 |
| Total Assets | $N/A | $20,170 | $21,950 | $19,650 | $20,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 350 | 460 | 500 |
| Accounts payable and accrued liabilities | 0 | 1,770 | 0 | 0 | 0 |
| Accrued Expenses | N/A | 10,670 | N/A | N/A | N/A |
| Other current liabilities | N/A | 14,060 | 13,960 | 15,210 | 15,620 |
| TOTAL | $N/A | $26,500 | $14,310 | $15,670 | $16,120 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 4,550 | 1,300 | 1,450 | 1,480 |
| TOTAL | $N/A | $4,550 | $1,300 | $1,450 | $1,480 |
| Total Liabilities | $N/A | $31,050 | $15,610 | $17,120 | $17,600 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 10 | 10 | 10 | 10 |
| Other shareholders' equity | 0 | -500 | 80 | -80 | -140 |
| TOTAL | $N/A | $67,040 | $67,590 | $67,160 | $66,870 |
| Total Liabilities And Equity | $0 | $98,090 | $83,200 | $84,280 | $84,470 |